Price Point
Total ReturnsTotal Returns (Price + Dividend) 
Chemkart India for the last several years.
Risk Adjusted Returns v/s
Returns Beta
News & Corporate ActionsNews
Is Chemkart India overvalued or undervalued?
As of 13 November 2025, Chemkart India has moved from an expensive to a very attractive valuation grade. The company is currently undervalued, as indicated by its PE ratio of 9.82, EV to EBIT of 6.24, and EV to EBITDA of 6.13, which are significantly lower than many peers in the industry. For instance, Elitecon International is classified as very expensive with a PE ratio of 320.89, while PTC India, which is also very attractive, has a PE ratio of 7.67. Chemkart India's strong return on capital employed (ROCE) at 40.41% and return on equity (ROE) at 20.46% further support its undervaluation. Despite recent stock performance lagging behind the Sensex, with a 1-week return of -7.21% compared to the Sensex's 1.40%, the company's fundamentals suggest significant upside potential. Overall, Chemkart India presents a compelling investment opportunity given its attractive valuation metrics relative to its peers....
Read MoreIs Chemkart India overvalued or undervalued?
As of 12 November 2025, Chemkart India has moved from a grade of does not qualify to expensive, indicating a significant shift in its valuation outlook. The company is currently considered overvalued. Key ratios include a PE ratio of 9.68, an EV to EBIT of 7.84, and an ROCE of 47.81%. In comparison to its peers, Chemkart India's PE ratio is notably lower than that of Elitecon International, which stands at 329.04, and much higher than PTC India, which is at 7.7, indicating a relative overvaluation. The recent stock performance shows a decline of 8.35% over the past week, contrasting with a modest gain of 1.21% in the Sensex, further supporting the view that Chemkart India is currently overvalued in the market....
Read More Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
01-Dec-2025 | Source : BSEIntimation of Analyst Meeting to be held on 04th December 2025.
Pursuant To Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations)
25-Nov-2025 | Source : BSEPursuant to the regulation 7(2)(b) of SEBI (prohibition of insider trading) regulations 2015 (PIT Regulation) we are enclosing herewith the disclosures received to the company under Regulation 7(2) (a)of PIT regulations along with Form C in respect of Acquisition of Equity Shares of the company.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
21-Nov-2025 | Source : BSEPursuant to the Regulation 30 read with Part A of Schedule II of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform that the management of the Company will be participating in the following conferences with Smallcap Spotlight Conference 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Key FactorsQuality key factors
Valuation key factors
Technicals key factors
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned ShareholdingShareholding Snapshot : Sep 2025
Shareholding Compare (%holding)
Promoters
None
Held by 0 Schemes
Held by 4 FIIs (0.95%)
Parul Shailesh Mehta (36.66%)
Aarth Aif Growth Fund (1.64%)
12.3%
FinancialHalf Yearly Results Snapshot (Consolidated) - Sep'25
Compare with Peers 
Growth in half year ended Sep 2025 is 14.51% vs -20.31% in Mar 2025
Growth in half year ended Sep 2025 is 14.04% vs -43.09% in Mar 2025
Annual Results Snapshot (Standalone) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Company CVAbout Chemkart India Ltd
Company Coordinates
